Dr. Lippman has authored more than 400 peer-reviewed publications and one of the standard texts on breast cancer. He is a director of Ascenta Therapeutics, Inc., a privately-held biotechnology company. He received a B.A., magna cum laude from Cornell and his M.D. from Yale where he was elected to Alpha Omega Alpha.He also served as Chief of the Division of Hematology-Oncology at Georgetown University Medical School and Head of the Medical Breast Cancer Section of the Medicine Branch of the National Cancer Institute.Marc E. Lippman, M.D., has served as a Director of Seattle Genetics since June 2000. Since May 2007, Dr. Lippman has served as the Kathleen and Stanley Glaser Professor of Medicine at the University of Miami Leonard M. Miller School of Medicine, where he also serves as the Deputy Director of the Sylvester Comprehensive Cancer Center. Previously, he served as the John G. Searle Professor and Chairman of the Department of Internal Medicine at the University of Michigan School of Medicine. Before that, Dr. Lippman was the Director of the Lombardi Cancer Research Center, Professor and Chairman of the Department of Oncology, and Professor of Medicine at Georgetown University Medical School.

Hematology-Oncology